Log in
Enquire now
Atomo Diagnostics

Atomo Diagnostics

Atomo Diagnostics is a Leichhardt, New South Wales-based designer and manufacturer of blood-based medical diagnostic and test devices.

OverviewStructured DataIssuesContributors

Contents

atomodiagnostics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Engineering
Engineering
Medical diagnostics
Medical diagnostics
Biosensor
Biosensor
Biomedical engineering
Biomedical engineering
Diagnosis
Diagnosis
Technology
Technology
...
Location
Leichhardt, New South Wales
Leichhardt, New South Wales
0
New South Wales
New South Wales
CEO
‌
John Kelly
0
Founder
‌
John Kelly
0
Phone Number
+612909947500
Full Address
Level 1, 3-5 George Street, Leichhardt, NSW, 20400
Investors
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
Allan Moss
Allan Moss
Transition Level Investments
Transition Level Investments
Global Health Investment Fund
Global Health Investment Fund
Founded Date
January 1, 2010
Total Funding Amount (USD)
7,050,000
Competitors
Tasso
Tasso
CFO
‌
Will Souter
0
Latest Funding Type
‌
Venture round
Country
Australia
Australia
0

Other attributes

Company Operating Status
Active
Wikidata ID
Q30271529
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Atomo Diagnostics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.